Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AMIXNASDAQ:CHEKOTCMKTS:SIGYOTCMKTS:UMGP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMIXAutonomix Medical$1.76-4.3%$1.86$1.52▼$50.00$4.34M-3.6315,425 shs16,991 shsCHEKCheck-Cap$0.85-0.5%$0.79$0.56▼$3.04$4.96M0.21378,690 shs7,217 shsSIGYSigyn Therapeutics$3.53$3.87$3.15▼$6.34$5.67M-1.04436 shsN/AUMGPUniversal Media Group$0.03-27.0%$0.04$0.02▼$0.29$957K0.1338,001 shs5,848 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMIXAutonomix Medical-4.35%-9.74%-10.66%-40.54%-96.54%CHEKCheck-Cap-0.53%-8.38%+25.94%+11.23%-62.16%SIGYSigyn Therapeutics0.00%0.00%-14.94%-14.32%-32.76%UMGPUniversal Media Group0.00%-34.34%-28.57%-30.67%-84.68%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMIXAutonomix Medical2.4123 of 5 stars3.52.00.00.01.91.71.3CHEKCheck-Cap0.5569 of 5 stars0.05.00.00.00.70.00.6SIGYSigyn TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AUMGPUniversal Media GroupN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMIXAutonomix Medical 3.00Buy$16.50837.50% UpsideCHEKCheck-Cap 0.00N/AN/AN/ASIGYSigyn Therapeutics 0.00N/AN/AN/AUMGPUniversal Media Group 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest UMGP, SIGY, CHEK, and AMIX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/29/2025AMIXAutonomix MedicalMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$5.00(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMIXAutonomix MedicalN/AN/AN/AN/A$8.12 per shareN/ACHEKCheck-CapN/AN/AN/AN/A$4.05 per shareN/ASIGYSigyn TherapeuticsN/AN/AN/AN/A($2.80) per shareN/AUMGPUniversal Media Group$30K31.89N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMIXAutonomix Medical-$15.43M-$12.93N/AN/AN/AN/A-212.48%-161.13%N/ACHEKCheck-Cap-$17.57M-$3.00N/A∞N/AN/AN/AN/A6/3/2025 (Estimated)SIGYSigyn Therapeutics-$4.15M-$4.57N/A∞N/AN/AN/A-1,147.41%N/AUMGPUniversal Media Group-$350K-$0.01N/A∞N/AN/AN/AN/AN/ALatest UMGP, SIGY, CHEK, and AMIX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2025Q1 2025SIGYSigyn TherapeuticsN/A-$0.42N/A-$0.42N/AN/A4/15/2025Q4 2024SIGYSigyn TherapeuticsN/A-$2.51N/A-$2.51N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMIXAutonomix MedicalN/AN/AN/AN/AN/ACHEKCheck-CapN/AN/AN/AN/AN/ASIGYSigyn TherapeuticsN/AN/AN/AN/AN/AUMGPUniversal Media GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMIXAutonomix MedicalN/A5.315.31CHEKCheck-CapN/A19.67N/ASIGYSigyn TherapeuticsN/A0.060.05UMGPUniversal Media GroupN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMIXAutonomix Medical10.78%CHEKCheck-Cap1.07%SIGYSigyn Therapeutics10.01%UMGPUniversal Media GroupN/AInsider OwnershipCompanyInsider OwnershipAMIXAutonomix Medical32.40%CHEKCheck-Cap0.48%SIGYSigyn Therapeutics78.46%UMGPUniversal Media GroupN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMIXAutonomix Medical12.46 million1.67 millionN/ACHEKCheck-Cap805.85 million5.82 millionNot OptionableSIGYSigyn Therapeutics51.61 million346,000Not OptionableUMGPUniversal Media Group2436.80 millionN/ANot OptionableUMGP, SIGY, CHEK, and AMIX HeadlinesRecent News About These CompaniesBeastie Boys, UMG settle lawsuits against Chili’s over ‘Sabotage’ adsMay 23 at 9:10 PM | msn.comBeastie Boys and UMG Settle Lawsuits With Chili’s Over ‘Sabotage’ Use in AdsMay 22 at 12:18 PM | msn.comPENN 2 Welcomes Universal Music Group in Headquarters MoveMay 22 at 7:17 AM | globest.comSalt-N-Pepa sue Universal over ownership of master recordings – UMG says it remains ‘committed to working towards an amicable resolution’May 21 at 9:16 PM | musicbusinessworldwide.comSalt-N-Pepa Sue Universal Music Group Over Music Rights and Album RemovalMay 21 at 9:16 PM | thesource.comUniversal Music Fires Back Against Salt-N-Pepa’s ‘Unreasonable Demands,’ Says It’s ‘Committed to Working Towards an Amicable Resolution’May 21 at 9:16 PM | msn.comUMG and Beastie Boys Settle Lawsuits Against Chili’s Over Social Media AdsMay 21 at 9:16 PM | billboard.comUniversal Music Group to Relocate New York Offices to Manhattan’s Penn DistrictMay 21 at 4:15 PM | rebusinessonline.comMatt Ellis named Chief Financial Officer of Universal Music GroupMay 13, 2025 | exchange4media.comUniversal Music Group N.V.: UNIVERSAL MUSIC GROUP APPOINTS MATT ELLIS AS CHIEF FINANCIAL OFFICERMay 12, 2025 | finanznachrichten.deUNIVERSAL MUSIC GROUP APPOINTS MATT ELLIS AS CHIEF FINANCIAL OFFICERMay 12, 2025 | finance.yahoo.comUniversal Music Group appoints Matt Ellis as new CFOMay 12, 2025 | investing.comUniversal Music Group Names Matt Ellis Chief Financial OfficerMay 12, 2025 | variety.com"UMG is trash" — Azealia Banks calls out Universal Music Group for filing to dismiss Drake amended lawsuitMay 10, 2025 | sportskeeda.comUMG Moves to Dismiss Drake’s Kendrick Lamar Lawsuit, Says Rapper Is Trying to ‘Save Face’ After ‘Not Like Us’May 10, 2025 | msn.comUniversal Music Group is so over Drake's sore loser lawsuitMay 9, 2025 | avclub.comUMG Seeks To Dismiss Drake’s Amended “Not Like Us” Defamation LawsuitMay 8, 2025 | yahoo.comWhy Universal Media Group is suing Crumbl for $23 millionMay 2, 2025 | fox13now.comUniversal Music Group Seeks to Terminate Your Internet Over Anime PiracyApril 25, 2025 | msn.com"Be careful what you wish for": UMG gives a fiery retort to Drake filing amended lawsuitApril 18, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeUMGP, SIGY, CHEK, and AMIX Company DescriptionsAutonomix Medical NASDAQ:AMIX$1.76 -0.08 (-4.35%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$1.78 +0.02 (+1.36%) As of 05/23/2025 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.Check-Cap NASDAQ:CHEK$0.85 0.00 (-0.53%) Closing price 05/23/2025 03:51 PM EasternExtended Trading$0.85 +0.00 (+0.52%) As of 05/23/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.Sigyn Therapeutics OTCMKTS:SIGY$3.53 0.00 (0.00%) As of 05/22/2025Sigyn Therapeutics, Inc., a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats. The company is also involved in evaluating the Sigyn Therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. In addition, it develops ChemoPrep to enhance the tumor site delivery of chemotherapy; ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis; and ImmunePrep to enhance the potential efficacy of immunotherapeutic antibodies. Sigyn Therapeutics, Inc. was founded in 2019 and is headquartered in San Diego, California.Universal Media Group OTCMKTS:UMGP$0.03 -0.01 (-26.97%) As of 05/23/2025 12:49 PM EasternUniversal Media Group Inc., a media company, produces and distributes media content worldwide. It produces On The Mike, a TV show that primarily include celebrity interviews, music concerts, and other events. The company was formerly known as Dalton Industries Inc. and changed its name to Universal Media Group Inc. in January 2016. Universal Media Group Inc. was founded in 1971 and is based in Boca Raton, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Advance Auto Parts Jumps on Surprise Earnings Beat Costco Stock at $1K: Dominance or Danger Zone? Williams-Sonoma: A Fundamentally Good Buy On Sale Now Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond? Alphabet Gets JPMorgan’s Vote of Confidence After Google I/O Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
